Lawrenceville, NJ, USA—May 29, 2018—ISPOR, the professional society for health economics and outcomes research, announced the Best Podium and Poster Research Presentation awardees for its ISPOR 2018 conference held in Baltimore, MD, USA on May 19-23, 2018. The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations at ISPOR’s conferences (ISPOR, ISPOR Europe, ISPOR Asia Pacific, and ISPOR Latin America). The winning research awards were given to the following individuals:


Best General Podium Presentations

  • Health Technology Assessment Agencies Consideration of Real-World Evidence [HT4] Ashley Jaksa, MPH, Context Matters, New York, NY, USA
  • Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living With HIV-1: A Canadian Cost-Utility Analysis [AV3] Erin Arthurs, GSK, Mississauga, ON, Canada
  • “It’s Tough to Make Predictions, Especially About the Future”: Comparing Life Expectancy Predictions Based on Period Versus Cohort Life Tables [VA3] Louis P. Garrison, University of Washington, Seattle, WA, USA 

Best Student Podium Presentations

  • Secondary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis [CV2] Xue Han, University of Southern California, Los Angeles, CA, USA
  • Trends in the Economic Value of Newly Approved Cancer Therapies in the US [VA2] Xiaohan Hu, University of Southern California, Los Angeles, CA, USA
  • Economic Consequences of Anti-HCV Antiviral Treatment Investment From the NHS Perspective [VA4] Francesco Saverio Mennini, Faculty of Economics, Centre for Economic and International Studies-Economic Evaluation and Health Technology Assessment, University of Rome Tor Vergata, Rome, Italy 

Best New Investigator Podium Research Presentations

  • Comparative Effectiveness of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation [CV3] Nicolae Done, Veterans Health Administration, Boston, MA, USA
  • Annual Change in Controlled Substance Opioid Prescribing and Concomitant Medications From an Urban Academic Emergency Department From 2011–2016 [HU1] JA Voelker, Jefferson College of Population Health at Thomas Jefferson University, Philadelphia, PA, USA
  • Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Duration in Genotype 1 Non-Cirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus [AV2] Christopher G Fawsitt, University of Bristol, Bristol, UK



Best General Poster Research Presentations

  • Comparison of Costs Associated With TURP and Prostatic Urethral Lift for Benign Prostatic Hyperplasia [PUK20] Andrzei Orlowski, Imperial College Health Partners, London, UK
  • Inpatient Admission Length of Stay and Costs Among Vascular Procedure Patients Receiving Perclose Proglide Suture-Mediated Closure Compared to Patients Receiving Surgical Cutdown for Closure of Large Bore Arterial Access [PCV61] Ellen R. Thiel, Truven Health Analytics, an IBM Company, Cambridge, MA, USA
  • Treatment With Prostacyclins Delays and Reduces Hospital Readmissions Among PAH Patients [PSY107] Peter Classi, United Therapeutics, Durham, NC, USA

Best Student Poster Research Presentations

  • Economic Burden of Renal Cell Carcinoma Among Older Adults in the Targeted Therapy Era [PCN212] Hrishikesh P. Kale, Virginia Commonwealth University, Richmond, VA, USA
  • Association Between Hydroxyurea Medication Adherence and Vaso-Occlusive Crisis Events Among Texas Medicaid Enrollees With Sickle Cell Disease [PSY63] Hyeun Ah Kang, The University of Texas at Austin, Austin, TX, USA
  • Comparative Effectiveness of Apixaban Versus Warfarin for the Prevention of Recurrent Venous Thromboembolism and Cardiovascular Diseases in Patients With Venous Thromboembolism [PCV20] Ghadeer Dawwas, University of Florida, Gainesville, FL, USA 

Best New Investigator Poster Research Presentations

  • Predictors and Incidence of Cardiovascular Events in Patients With Rheumatoid Arthritis [PMS9] Elmor D Pineda, Baylor Scott & White Health, Temple, TX, USA
  • Prescription Opioid Use Among Children and Adolescents With Asthma in the United States: National Estimates From 2011 to 2015 [PRS41] Saurabh P Nagar, RTI Health Solutions, Research Triangle Park, NC, USA
  • Real-World Outcomes and Medication Adherence to Disease Modifying Therapies Among Patients With Multiple Sclerosis [PND8] Dante M. Grassi, Geisinger, Danville, PA, USA

Additional information on ISPOR 2018 can be found here. Released presentations from the conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORBaltimore.


ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: | LinkedIn: | Twitter: (@ISPORorg) | YouTube: | Facebook: | Instagram:

Meeting Link: ISPOR 2018, May-2018